4//SEC Filing
PHARMACOPEIA INC 4
Accession 0001273013-08-000072
CIK 0001273013operating
Filed
Dec 23, 7:00 PM ET
Accepted
Dec 24, 10:51 AM ET
Size
6.0 KB
Accession
0001273013-08-000072
Insider Transaction Report
Form 4
PHARMACOPEIA INCPCOP
MOLLICA JOSEPH A
Director
Transactions
- Disposition to Issuer
Common Stock
2008-12-23−141,977.07→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to merger agreement between Pharmacopeia, Inc. ("Pharmacopeia"), Ligand Pharmaceuticals Incorporated ("Ligand") , Margaux Acquisition Corp., a wholly-owned subsidiary of Ligand, and Latour Acquisition, LLC, a wholly-owned subsidiary of Ligand, in exchange for approximately 84,973.28 shares of Ligand common stock having a market value of $2.58 per share on the effective date of the merger and $44,012.89 in cash, without interest. In addition, the reporting person received one contingent value right ("CVR") for each share of the Pharmacopeia common stock disposed of in the merger by the reporting person. The CVRs provide each holder the right to receive approximately $0.50 per share if Ligand enters into a license, sale, development, marketing or option agreement with respect to certain product candidates (other than any agreement with Bristol-Myers Squibb Company or any of its affiliates) on or prior to December 31, 2011.
Documents
Issuer
PHARMACOPEIA INC
CIK 0001273013
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001273013
Filing Metadata
- Form type
- 4
- Filed
- Dec 23, 7:00 PM ET
- Accepted
- Dec 24, 10:51 AM ET
- Size
- 6.0 KB